Nutraceutical Int'l Corp. (NUTR) Earning Positive Press Coverage, Study Shows

Press coverage about Nutraceutical Int'l Corp. (NASDAQ:NUTR) has trended positive on Thursday, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nutraceutical Int'l Corp. earned a media sentiment score of 0.33 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.2965958239071 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Separately, BidaskClub downgraded shares of Nutraceutical Int'l Corp. from a “sell” rating to a “strong sell” rating in a report on Sunday, July 16th.

WARNING: “Nutraceutical Int'l Corp. (NUTR) Earning Positive Press Coverage, Study Shows” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at

About Nutraceutical Int'l Corp.

Nutraceutical International Corporation is an integrated manufacturer, marketer, distributor and retailer of nutritional supplements and other natural products. The Company’s products include vitamins and minerals; herbs; specialty formulas; personal care products; liquid nutritional products; homeopathics; functional foods, and other products.

Insider Buying and Selling by Quarter for Nutraceutical Int'l Corp. (NASDAQ:NUTR)

What are top analysts saying about Nutraceutical Int'l Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nutraceutical Int'l Corp. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit